Richard R. Pettingill joined the board of directors for MAKO Surgical, a medical device company manufacturing robotic arms for use during knee surgery, according to a company news release.
The Latest
As the team physician for Tuscola High School, Franklin High School and Haywood Christian Academy, Christofer Catterson, MD, an orthopedic surgeon and medical director for Haywood Sports Medicine in Clyde, N.C., is a proven leader in youth sports medicine. Recently,…
A Consumer Reports National Research Center survey showed consumers believe pharmaceutical companies have too much influence on a physician's decision to prescribe certain drugs, according to a Web MD report.
An increasing trend in orthopedics is the use of biological treatment for bone and cartilage repair. According to an article published in The Journal of Bone and Joint Surgery, biologics are also on the rise for spinal surgery solutions. Clinical…
Stryker announced an agreement to acquire Gaymar Industries, a company that supports surface and pressure ulcer management solutions as well as temperature management, for approximately $150 million in a transaction which is expected to close on Oct. 1, according to…
Co-founders of The Brain and Spine Surgeons of Orange County Christopher Duma, MD, and Richard Kim, MD, joined the Hoag Neurosciences Institute's multispecialty center in Newport Beach, Calif., according to a Daily Pilot report.
Biochemical differences between left- and right-handed pitchers lead to a higher population of left-handed pitchers and an increased risk of shoulder injury for those pitchers, according to a study published in The Journal of Sports Medicine.
Nebraska Orthopaedic Hospital in Omaha will provide a free injury evaluation and treatment clinic on Friday nights in order to accommodate fall sports athletes, according to a hospital news release.
The FDA sent Johnson & Johnson a letter of warning because the company improperly marketed two products under the DePuy Orthopaedics unit, according to a redOrbit.com report.
After lowering profit forecasts for defibrillators and spinal products, Medtronic's share prices fell more than they had in the past 21 months, according to a Bloomberg Businessweek report.